Yanfeng Pan

450 total citations
22 papers, 313 citations indexed

About

Yanfeng Pan is a scholar working on Cancer Research, Molecular Biology and Epidemiology. According to data from OpenAlex, Yanfeng Pan has authored 22 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Yanfeng Pan's work include Cancer-related molecular mechanisms research (7 papers), Hepatitis B Virus Studies (6 papers) and RNA modifications and cancer (5 papers). Yanfeng Pan is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Hepatitis B Virus Studies (6 papers) and RNA modifications and cancer (5 papers). Yanfeng Pan collaborates with scholars based in China, Germany and United States. Yanfeng Pan's co-authors include Tao Qin, Qiang Fu, Mingxing Hu, Lijie Song, Tao Qin, Xu Zhang, Liuxing Wang, Zujiang Yu, Lei Feng and Zhiwei Chang and has published in prestigious journals such as The Journal of Infectious Diseases, World Journal of Gastroenterology and Poultry Science.

In The Last Decade

Yanfeng Pan

21 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanfeng Pan China 9 179 164 46 46 39 22 313
You Xie China 8 180 1.0× 127 0.8× 67 1.5× 30 0.7× 30 0.8× 12 312
Adam Idica United States 11 204 1.1× 79 0.5× 23 0.5× 125 2.7× 85 2.2× 20 458
Jiajia Song China 12 121 0.7× 83 0.5× 60 1.3× 46 1.0× 18 0.5× 38 296
Zhihui Dai China 10 373 2.1× 261 1.6× 12 0.3× 65 1.4× 19 0.5× 17 485
Varsha Shridhar United States 8 200 1.1× 125 0.8× 35 0.8× 44 1.0× 86 2.2× 17 445
Hong-Xin Peng China 12 186 1.0× 174 1.1× 47 1.0× 45 1.0× 59 1.5× 19 420
Rocío Lavado-Valenzuela Spain 8 190 1.1× 65 0.4× 18 0.4× 66 1.4× 22 0.6× 16 333
Birte Möhlendick Germany 14 134 0.7× 162 1.0× 155 3.4× 53 1.2× 37 0.9× 32 502
Ceen‐Ming Tang United Kingdom 6 160 0.9× 151 0.9× 21 0.5× 21 0.5× 74 1.9× 8 419
Emi Hamano Japan 9 184 1.0× 116 0.7× 53 1.2× 72 1.6× 94 2.4× 11 429

Countries citing papers authored by Yanfeng Pan

Since Specialization
Citations

This map shows the geographic impact of Yanfeng Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfeng Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfeng Pan more than expected).

Fields of papers citing papers by Yanfeng Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfeng Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfeng Pan. The network helps show where Yanfeng Pan may publish in the future.

Co-authorship network of co-authors of Yanfeng Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfeng Pan. A scholar is included among the top collaborators of Yanfeng Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfeng Pan. Yanfeng Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Dong, Yanfeng Pan, Kewei Ma, et al.. (2025). Eggshell depigmentation in the late phase of production is associated with altered Microbiota and Metabolism of the uterus in laying hens. Poultry Science. 104(8). 105258–105258.
2.
Zhang, Xu, et al.. (2022). A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma. Cancer Management and Research. Volume 14. 3037–3046. 4 indexed citations
3.
Pan, Yanfeng, Qiang Fu, Xu Zhang, et al.. (2022). Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity. Cell Biology and Toxicology. 39(5). 2069–2087. 6 indexed citations
4.
Hu, Mingxing, et al.. (2020). LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia. Biomedicine & Pharmacotherapy. 125. 109703–109703. 54 indexed citations
5.
Hu, Mingxing, et al.. (2020). Identification of predictive factors in hepatocellular carcinoma outcome: A longitudinal study. Oncology Letters. 20(1). 765–773. 4 indexed citations
6.
Pan, Yanfeng, Xue‐jie Yu, Qingqing Li, et al.. (2020). Epidemiological and Clinical Characteristics of 26 Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Carriers. The Journal of Infectious Diseases. 221(12). 1940–1947. 45 indexed citations
7.
Pan, Yanfeng, Qingqing Li, Xue‐jie Yu, et al.. (2020). Retrospective analysis of the effect of current clinical medications and clinicopathological factors on viral shedding in COVID‑19 patients. Biomedical Reports. 13(6). 1–1. 1 indexed citations
8.
Pan, Yanfeng, et al.. (2017). Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA. Biomedicine & Pharmacotherapy. 87. 669–677. 16 indexed citations
9.
10.
Pan, Yanfeng, Tong Su, Lidan Chen, & Tao Qin. (2017). Differential expression of genes in HepG2 cells caused by UC001kfo RNAi as shown by RNA-seq. Journal of Huazhong University of Science and Technology [Medical Sciences]. 37(4). 510–515. 2 indexed citations
11.
Pan, Yanfeng, Yan Zheng, Tao Qin, et al.. (2016). Disease progression in Chinese patients with hepatitis C virus RNA-positive infection via blood transfusion. Experimental and Therapeutic Medicine. 12(5). 3476–3484. 3 indexed citations
12.
Song, Lijie, Weijie Zhang, Zhiwei Chang, et al.. (2015). PU.1 Is Identified as a Novel Metastasis Suppressor in Hepatocellular Carcinoma Regulating the miR-615-5p/IGF2 Axis. Asian Pacific Journal of Cancer Prevention. 16(9). 3667–3671. 23 indexed citations
13.
Qin, Tao, Cuimei Liu, Yanfeng Pan, et al.. (2014). Effect of the IkBα mutant gene delivery to mesenchymal stem cells on rat chronic pancreatitis. Genetics and Molecular Research. 13(1). 371–385. 8 indexed citations
14.
Qin, Tao, Qiang Fu, Yanfeng Pan, et al.. (2014). Expressions of miR-22 and miR-135a in acute pancreatitis. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(2). 225–233. 22 indexed citations
15.
Pan, Yanfeng, Tao Qin, Lei Feng, & Zujiang Yu. (2013). Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(1). 96–101. 33 indexed citations
16.
Pan, Yanfeng, Lei Feng, Xianqiang Zhang, et al.. (2011). Role of long non-coding RNAs in gene regulation and oncogenesis.. PubMed. 124(15). 2378–83. 24 indexed citations
17.
Liang, Hongxia, et al.. (2010). [A cross-sectional survey of occult hepatitis B virus infection in HIV-infected patients in acquired immune deficiency syndrome area].. PubMed. 24(6). 442–4. 2 indexed citations
18.
He, Yongwen, Chunxia Guo, Yanfeng Pan, Cheng‐Yuan Peng, & Zhihong Weng. (2008). Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro. World Journal of Gastroenterology. 14(10). 1592–1592. 21 indexed citations
19.
Pan, Yanfeng, et al.. (2007). The role of IκBα in TNF-α-induced apoptosis in hepatic stellate cell line HSC-T6. Journal of Huazhong University of Science and Technology [Medical Sciences]. 27(4). 407–410. 2 indexed citations
20.
Pan, Yanfeng, et al.. (2007). Detection of hepatitis C virus in serum and peripheral blood mononuclear cells by two reverse transcription polymerase chain reactions. Chinese Medical Journal. 120(5). 431–433. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by You Xie Breakdown of academic impact, for papers by Adam Idica Breakdown of academic impact, for papers by Jiajia Song Breakdown of academic impact, for papers by Zhihui Dai Breakdown of academic impact, for papers by Varsha Shridhar Breakdown of academic impact, for papers by Hong-Xin Peng Breakdown of academic impact, for papers by Rocío Lavado-Valenzuela Breakdown of academic impact, for papers by Birte Möhlendick Breakdown of academic impact, for papers by Ceen‐Ming Tang Breakdown of academic impact, for papers by Emi Hamano
Rankless by CCL
2026